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Mammalian brain possesses ryanodine-sensitive Ca2+ channels, which in muscle cells mediate rapid Ca2+ release from
intracellular stores during excitation-contraction coupling. Analysis of bovine brain ryanodine receptor (RyR) channels
suggests specific expression of the cardiac-muscle RyR isoform in mammalian brain. Localization using cardiac-muscle
RyR-specific antibodies and antisense RNA revealed that brain RyRs were present in dendrites, cell bodies and terminals
of rat forebrain, and highly enriched in the hippocampus. Activity of skeletal-muscle RyR channels is coupled to
sarcolemmal voltage sensors, in contrast with cardiac-muscle RyR channels, which are known to be Ca2+-induced Ca2+-
release channels. Thus Ca2+-induced Ca2+ release from intracellular stores mediated by brain RyR channels may be a
major Ca2+-signalling pathway in specific regions of mammalian brain, and hence may play a fundamental role in
neuronal Ca2+ homoeostasis.
INTRODUCTION
Transient elevations of cytoplasmic free Ca2+ induced by
release from non-mitochondrial intracellular stores, can be (i)
triggered by a change in surface membrane potential, or (ii)
mediated by a series of voltage-independent steps via the for-
mation of a chemical second messenger, inositol 1,4,5-tris-
phosphate (IP3). The voltage-dependent mechanism of intra-
cellular Ca2+ release has been extensively studied in striated
muscle, and is commonly referred to as excitation-contraction
(E-C) coupling (Catterall, 1991). In E-C coupling, an action
potential is propagated along the muscle surface membrane and
its infoldings, the transverse tubular (T-) system. On reaching the
T-system, the depolarizing signal is communicated to the sarco-
plasmic reticulum (SR) and triggers therefrom a large and rapid
release of Ca2+ ions via a Ca2+-release channel (Lai & Meissner,
1989). Ca2+ release from cardiac SR is triggered by extracellular
Ca2+ ions which enter the muscle cell through voltage-dependent
Ca2+ channels (Cannell et al., 1987; Niibauer et al., 1989).
Skeletal-muscle SR Ca2+ release, however, does not require
extracellular Ca2+, but rather is believed to be coupled via a
direct physical interaction with a voltage-sensing molecule in the
T-system (Rios & Pizarro, 1988).
Identification of the plant alkaloid ryanodine as a release-
channel-specific probe, has enabled the biochemical isolation
(Campbell et al., 1987; Inui et al., 1987a,b; Lai et al., 1988a,b),
functional reconstitution (Lai et al., 1988b; Smith et al., 1988;
Anderson et al., 1989) and subsequentcDNA cloning (Takeshima
et al., 1989; Zorzato et al., 1990; Otsu et al., 1990; Nakai et al.,
1990) of skeletal- and cardiac-muscle ryanodine receptor (RyR)-
Ca2+-release channels. These studies have shown that skeletal-
and cardiac-muscle RyR channels are similar, but distinct,
proteins that comprise homotetrameric 30 S complexes of
Mr - 565000 subunits with pl - 4 (Lai et al., 1989). The four
subunits form into four-leaf-clover-like (quatrefoil) patterns that
display a morphology identical with the 'feet' structures that
bridge the T-SR junctional gap (Ferguson et al., 1984). The
isolated and reconstituted skeletal- and cardiac-muscle RyR
channels can be activated Ca2+ ions, ATP and caffeine, and
inhibited by Mg2+ ions and Ruthenium Red, as has been
demonstrated for the native SR Ca2+-release channel (Smith et
al., 1985, 1986; Rousseau et al., 1986). Low concentrations of
ryanodine modify the RyR channels into a permanently open
state of decreased (about half) conductance, whereas higher
concentrations of ryanodine cause the closing of the channel
(Rousseau et al., 1987; Lai et al., 1989).
The second messenger, IP3, has also been shown to cause the
release of Ca2+ ions from intracellular membrane compartments
of both excitable and non-excitable tissues (Berridge & Irvine,
1984, 1989). A homotetrameric IP3 receptor (IP3R) complex
comprising subunits of Mr - 320000 has been isolated from
mammalian cerebellum and smooth muscle (Supattapone et al.,
1988; Chadwick et al., 1990; Maeda et al., 1991). Reconstitution
studies have shown the purified cerebellar IP3R channel to
behave differently from the muscle RyR channel with regard to
unitary conductance and pharmacology (Ferris et al., 1989).
Single-channel measurements have indicated that the 1P3-sen-
sitive Ca2+ channel has a fourfold lower conductance for Ca2+
ions than the RyR channel (- 25 pS versus - 100 pS), and can
be activated by IP3 and inhibited by heparin (Erlich & Watras,
1988; Maeda et al., 1991; Bezprozvanny et al., 1991). De-
termination of the cerebellar IP3R primary structure has revealed
its homology with the muscle RyR (Furuichi et al., 1989; Mignery
et al., 1990), suggesting that both are members of a new class of
intracellular Ca2+ channels (Gill, 1989).
Although much effort has focused on the role ofthe RyR-Ca2+-
release channel in muscle E-C coupling, recent evidence has
indicated that in mammalian brain, in addition to the IP3R
Abbreviations used: E-C, excitation-contraction; SR, sarcoplasmic reticulum; RyR, ryanodine receptor; IP3, inositol 1,4,5-trisphosphate; IP3R, 1P3
receptor; PMSF, phenylmethanesulphonyl fluoride; STE, 0.5 M-NaCl/10 mM-Tris/HCl (pH 8)/i mM-EDTA; SSC, 0.15 M-NaCl/15 mM-sodium
citrate/HCl, pH 7; PBS, phosphate-buffered saline; WB - C, whole brain minus cerebellum; mAb, monoclonal antibody.
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channel, there also exists a ryanodine-sensitive Ca21 channel.
Ryanodine binding, sedimentation and immunoblot analysis, as
well as single-channel measurements with brain microsomes,
have shown that a high-affinity brain RyR shares many of the
characteristics of muscle Ca2+-release channels (Ashley, 1989;
Lai et al., 1990; McPherson & Campbell, 1990; McPherson
et al., 1991). In this report, we describe studies of the brain
RyR-Ca2+-release channel complex that provide novel evidence
for expression and localization of the cardiac RyR isoform in
mammalian brain.
EXPERIMENTAL
Preparation of bovine brain and cerebellum microsomes
Bovine cerebellum and whole brain minus cerebellum
(WB - C) were homogenized (Waring blender, 2 x 30 s, high) in
10 vol. of buffer A [0.32 M-sucrose, 10 mM-Pipes (sodium salt),
pH 7.4, 0.5 mM-EDTA, 0.2 mM-phenylmethanesulphonyl fluor-
ide (PMSF), 1 mM-benzamidine, 10 /M-leupeptin, 1 tM-pepstatin
A and 100 nM-aprotinin]. Homogenates were centrifuged for
20 min at 4000 g (Sorvall GSA), and the supernatant passed
through three layers of cheesecloth and re-centrifuged for 60 min
at 100000 g (Beckman, Ti45 rotor). The 100000 g pellets were
resuspended in 4 vol. of buffer A without EDTA, and loaded on
to a 20-40% linear sucrose gradient in 0.6 M-KCl/10 mM-Pipes
(potassium salt), (pH 7)/0.2 mM-PMSF/ 1 uM-leupeptin, and cen-
trifuged for 16 h at 130000 g (Beckman, SW28). Cerebellum and
WB -C microsomes sedimenting to the 25-35 % sucrose region
were diluted with 2 vol. of 0.4 M-KCI, pelleted at 100000 g and
resuspended in 0.3 M-sucrose/5 mM-Pipes (potassium salt),
(pH 7), and stored in approx. 5 ml portions at -75 'C. All
procedures were performed at 4 'C.
I3HlRyanodine binding
Bovine cerebellum and WB -C microsomes (2-5 mg/ml) were
incubated with various concentrations of [3H]ryanodine as speci-
fied in the Figure legends, in buffer B [1.0 M-NaCl, 5 mM-AMP,
1 mM-di-isopropyl fluorophosphate, 10 uM-leupeptin, 20 mm-
Pipes (sodium salt), pH 7.0] for 3 h at 37 'C. Samples of the vesicle
suspensions were then (i) counted to determine total radioactivity,
(ii) centrifuged for 30 min at 90000 g (Beckman Airfuge) to
determine free [3H]ryanodine and (iii) filtered, after dilution with
25 vol. of ice-cold water, on a Whatman GF/B filter disc soaked
in 1 % polyethyleneimine. After three 5 ml rinses with ice-cold
water, filters were counted to obtain a value for bound [3H]-
ryanodine. Non-specific binding of [3H]ryanodine was assessed
in the presence of a 1000-fold excess of unlabelled ryanodine and
was equivalent to 0.3 pmol/mg of protein at 40 nM-[3H]-
ryanodine.
Purification of bovine brain RyR
Bovine WB-C microsomes (3 mg of protein/ml) were solu-
bilized in buffer C (buffer B plus 100 ,tM-EGTA, 200 4uM-Ca2+
and 0.3 mM-dithiothreitol) containing 120 nM-[3H]ryanodine,
1.55% Chaps and 5 mg of phosphatidylcholine/ml, for 2 h at
23 'C. Solubilized proteins (3 ml, 2.5 mg of protein/ml) were
loaded on to a 9 ml cushion of 7 % sucrose in buffer C plus 1 %
Chaps and 5 mg of phosphatidylcholine/ml, above a 24 ml
10-20% linear sucrose gradient in buffer C plus 0.5% Chaps
and 5 mg ofphosphatidylcholine/ml. Gradients were centrifuged
for 16 h at 130000 g, 2 'C (Beckman SW28). Fractions ofapprox.
2 ml were collected, analysed for [3H]ryanodine content, and the
- 30 S [3H]RyR peak fractions were pooled and concentrated
(Centriprep 30, Amicon). Concentrates were diluted to approx.
5% sucrose in buffer C plus 0.1 % Chaps, then loaded (2 ml)
on to a second 10-20% linear sucrose gradient (34 ml in buffer
C plus 1 % Chaps). After centrifugation, fractionation and
analysis of [3H]ryanodine content, the fractions were concen-
trated separately. Skeletal- and cardiac-muscle RyRs were iso-
lated as previously described (Lai et al., 1988a,b; Anderson
et al., 1989).
Antibody production
Polyclonal antiserum (G715) against purified rat skeletal-
muscle RyR was raised in rabbits, as previously described
(Meissner et al., 1989). Cardiac monoclonal antibodies (mAbs)
were produced in Balb/c mice immunized with purified canine
cardiac RyR (Anderson et al., 1989). Immunized mouse spleen
cells were fused with P3X 63AG 8.653 myeloma cells at a 1: 1
ratio. Hybridoma supernatants were screened by e.l.i.s.a. using
purified dog cardiac RyR, and by immunoblotting with dog
cardiac microsomal SR as described below. Immunoblot analyses
and immunolocalization studies with cardiac RyR-specific anti-
bodies described in this report were performed with mAbs C2-
997 and C3-33 of the IgM and IgGI subtype respectively. Rabbit
antiserum to mouse brain IP3R C-terminus peptide was a gift
from Dr. T. C. Sudhof (Mignery et al., 1989).
SDS/PAGE and immunoblot analysis
SDS/PAGE was performed (Laemmli, 1970) using 3-12%
(w/v) linear polyacrylamide gradient and 3 % (w/v) stacking
gels. Samples were denatured for 3 min at 95 'C in 0.1 M-
Tris/HCl (pH 6.8)/2 % SDS/3 % 2-mercaptoethanol/10 %
glycerol. The acrylamide/bisacrylamide ratio was 39:1. Gels
were either stained with Coomassie Brilliant Blue R-250 or
silver (Oakley et al., 1980).
Proteins for immunoblot analysis were transferred to Im-
mobilon poly(vinylidene difluoride) membranes (Millipore) at
15 'C, for 1 h at 400 mA, then at 1500 mA for 12-15 h. Transfer
membranes were blocked with 5 % non-fat dried-milk proteins,
then probed with either skeletal RyR antiserum G715 (1: 100 and
1: 1000), cardiac RyR mAb (hybridoma supernatants, 1: 10) or
IP3R antiserum (1: 500), as previously described (Meissner et al.,
1989). Blots were developed with peroxidase-coupled secondary
antibodies and 3,3'-diaminobenzidine/H202.
Electron microscopy
Bovine WB-C RyR purified as described above except in the
absence of exogenous phospholipid was analysed by negative-
stain electron microscopy. A sample (5 ll) of purified RyR was
applied to a carbon-coated grid, previously glow-discharged,
washed with three drops of 20% uranyl acetate and air-dried.
Quatrefoil images were recorded at 80 kV using a Zeiss 902
electron microscope at a magnification of x 85000.
Single-channel recordings
Single-channel measurement of bovine brain RyR channels
was performed using the planar lipid-bilayer technique as de-
scribed for purified muscle RyRs (Lai et al., 1988a,b; Anderson
et al., 1989). Chaps-solubilized brain 30 S fractions from a single
gradient, isolated in the absence of [3H]ryanodine, were
incorporated into Mueller-Rudin-type bilayers containing
phosphatidylethanolamine, phosphatidylserine and phospha-
tidylcholine in the proportions 5:3:2 (by wt.; in n-decane).
Samples of protein (0.2-2,l) were added to one side (defined as
cis) of the bilayer apparatus. Unless otherwise indicated, sym-
metrical solutions of buffered KCI [250 mM-KCl, 20 mM-Pipes
(potassium salt), pH 7.0, 150 #uM-CaCl2 and 100 ,tM-EGTA] were
used to record channel currents. Channels incorporating
spontaneously into the bilayer were detected as stepwise increases
in current. Electrical signals were filtered at 300 Hz and digitized
at 2 kHz for storage on a hard disc.
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Immunolocalization
Intact male rats (approx. 250 g) were perfused with 2% (v/v)
paraformaldehyde in 10 mM-sodium phosphate buffer, pH 7.4,
followed by 100% sucrose in phosphate-buffered saline (PBS;
0.15 M-NaCl and 10 mM-sodium phosphate), pH 7.4, under
chloral hydrate anaesthesia. Brains were dissected, incubated in
PBS containing 150% (w/v) sucrose, then frozen in liquid N2-
cooled isopentane. Serial frozen sections (8-10 ,um) were thaw-
mounted on to gelatin-coated slides and stored at -20 °C before
avidin-biotin peroxidase immunostaining (Sar, 1985; Sar et al.,
1987). Sections were air-dried and incubated with 1-5 4ug/ml of
affinity-purified mouse IgGI mAb C3-33 to the dog cardiac RyR,
for 16-20 h at 4 'C. Slides were then washed in PBS and incubated
with biotinylated anti-mouse IgG (1:200) and then with avidin-
peroxidase (1:200) (Vector Labs) for 30 min at 23 'C. After
being washed with PBS, sections were developed in 3,3'-diamino-
benzidine/H202 for 10 min, dried and mounted with permount.
Hybridization in situ
A human cardiac RyR cDNA (nucleotides 3644-5500) cloned
into Bluescript II (Stratagene, La Jolla, CA, U.S.A.) was
linearized with BamHI or EcoRV. Antisense and sense RNA
probes were labelled with digoxigenin-UTP by transcription in
vitro according to the Boehringer digoxigenin-RNA-labelled kit.
Digoxigenin-RNA probes were cut to an average length of
180 bp by alkaline hydrolysis before use (Cox et al., 1984).
Adult rat brains were bisected sagittally and immediately
frozen in powdered dry ice. Sagittal sections (10 ,um) collected on
gelatin-chrome alum-coated slides, were dried and fixed in 4%
paraformaldehyde/PBS, pH 7.4, for 1-2 h at 23 'C. Sections
were dehydrated in an ascending series of alcohol and stored dry
at -70 'C until use. Slides were rehydrated through a descending
series of alcohol to PBS, treated with proteinase K (10 ,tg/ml) for
5 min, then refixed in 4% paraformaldehyde/PBS, pH 7.4, for
20 min, and acetic anhydride for 10 min at 23 'C (Wilkinson et
al., 1987). After dehydration as above, slides were hybridized
overnight at 45 'C with digoxigenin-labelled cardiac-muscle RyR
RNA probe (5 ,ug/ml) in 25 1dl of hybridization mixture (Xue et
al., 1990). Sections were washed in 4 x SCC for 5, 15 and 30 min
at 23 0C and treated with 20,ug of RNAase A/ml in 0.5 M-
NaCl/10 mM-Tris/HCl (pH 8)/i mM-EDTA (STE), for 30 min
at 37 'C. After further washes in STE for 30 min at 37 0C,
2 x SSC for 30 min at 45 'C and twice in 0.1 x SSC for 15 min at
55 'C, each section was finally dehydrated as above and air-
dried. Digoxigenin-labelled RNA was immunologically detected
according to the Boehringer digoxigenin-RNA-labelling kit, but
with 10% skimmed milk in 0.1 M-Tris/HCl (pH 7.5)/0.15 M-
NaCl as the blocking agent.
Northern-blot analysis
Bovine brain (10 4ug), cardiac (1 jug) and skeletal (1 ,ug) muscle
poly(A)+ RNA was fractionated on a 0.8% denaturing agar-
ose/formaldehyde gel and transferred to Genescreen membrane
(NEN-Dupont) under alkaline conditions (Sambrook et al.,
1989). Blots were hybridized with [ac-32P]dCTP-labelled cDNA
probes (1 x 109 d.p.m./,ug; Feinberg & Vogelstein, 1984) from
the human cardiac RyR (nucleotides 3644-5500) or rabbit
skeletal-muscle RyR (nucleotides 2547-4717), in 1% SDS/1 M-
NaCl/ IO % dextran sulphate/ IO 4ug of denatured salmon sperm/
ml at 65 'C for 18 h. Washes for 30 min with 2 x SSC and then
0.1 x SSC at room temperature were performed before auto-
radiography on Fuji RX film.
Materials
[3H]Ryanodine (54.7 Ci/mmol) was obtained from DuPont-
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New England Nuclear and ryanodine from Agrisystems In-
ternational (Wind Gap, PA, U.S.A.). Peroxidase-conjugated
secondary antibodies were from Calbiochem, Chaps and RNA-
labelling kit from Boehringer-Mannheim, proteinase inhibitors
and SDS/polyacrylamide gel standards from Sigma, and phos-
pholipids from Avanti Polar Lipids (Birmingham, AL, U.S.A.).
RESULTS
[3HjRyanodine binding to bovine brain microsomes
Previous studies with skeletal- and cardiac-muscle SR indicated
that high-affinity ryanodine binding is dependent on [Ca2+] and
ionic strength (Lai & Meissner, 1989). Scatchard analysis of
ryanodine binding to WB-C microsomes, under optimal con-
ditions for binding to muscle RyRs (100 /M free Ca2+ and 1 M-
NaCl), indicated the presence of a single high-affinity site with a
Kd of 3 nm and Bmax of 0.25 pmol/mg (Fig. la). Fewer specific
binding sites were observed with bovine cerebellum microsomes,
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Fig. 1. Ryanodine binding to bovine whole-brain microsomes
(a) Scatchard analysis of [3H]ryanodine binding. Bovine WB-C
microsomes (2 mg of protein/ml) were incubated for 3 h at 37 °C in
buffer B containing 100 1uM-EGTA, 200 /M-Ca2" and 1-40 nm-
[3H]ryanodine. Specific [3H]ryanodine binding was determined as
described in the Experimental section. (b) Rate of [3H]ryanodine
dissociation with or without 200 ,M-ryanodine. Bovine WB -C
microsomes (5 mg of protein/ml) were incubated for 3 h at 37 °C in
buffer B containing 100 /vM-free Ca2l and 18 nM-[3H]ryanodine.
Dissociation of[3H]ryanodine from the high-affinity site was initiated
by diluting microsomes 10-fold into medium B at 37 °C containing
the indicated concentrations of free Ca2" and unlabelled ryanodine.
Bound ryanodine was determined at various times as described
in the Experimental section. 0, 0.01 /sM-Ca2"; 0, 0.01 /tM-









4 6 8 10 12 14 16 18
Fraction no.
4 29
Fig. 2. Immunoblot analysis of bovine whole brain and cerebellum micro-
somes
Bovine WB -C (lane 1) and cerebellum (lane 2) microsomes were
electrophoresed through SDS/polyacrylamide gels (3-12% gels)
(100 jug of protein/lane in a and b, 20,g/lane in c), transferred to
Immobilon membrane, and probed with skeletal-muscle RyR anti-
serum G715 (a), cardiac-muscle RyR mAb C2-997 (b) or IP3R
antiserum (c). Solid arrowheads indicate the positions of Mr
standards ( x 10-') myosin, f8-galactosidase, phosphorylase b, BSA,
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< 0.02 pmol/mg (results not shown). In studies with muscle SR,
ryanodine sites of low affinity have been identified in addition to
the high-affinity site (Lai et al., 1989; McGrew et al., 1989;
Pessah & Zimanyi, 1991). Occupation of low-affinity sites de-
creased the dissociation rate of bound ryanodine from high-
affinity site, suggesting that co-operative interactions occurred
between high- and low-affinity sites. To determine whether a
similar phenomenon existed with the brain RyR, we tested for
low-affinity sites by initially labelling WB -C microsomes 'with
[3H]ryanodine in 100,M free Ca2+ to optimize high-affinity
binding. Labelled membranes were diluted into 0.01 /M free Ca2+
with or without 200 /M unlabelled ryanodine or 100 M free
Ca21 with or without 200,M unlabelled ryanodine (Fig. lb).
Dilution into 0.01 #UM free Ca2+, a concentration that minimizes
rebinding of dissociated [3H]ryanodine, resulted in loss of bound
[3H]ryanodine within 1 h. Dilution into 100 uM free Ca2+, a
condition that favours high-affinity binding, resulted in in-
complete dissociation of bound [3H]ryanodine, due to partial
rebinding of dissociated [3H]ryanodine. In contrast, a dramatic
decrease in [3H]ryanodine dissociation from the high-affinity site
was observed under both conditions when 200 #M unlabelled
ryanodine was present in the dilution medium. These studies
suggest that brain RyRs, like muscle RyRs, possess both high-
and low-affinity ryanodine-binding sites. Further, the [3H]ryano-
dine-displacement data suggest positive co-operativity between
these classes ofbinding site (Lai et al., 1989), in which occupation
of low-affinity sites results in conformational change(s) that
occludes dissociation from the high-affinity site.
Immunoblot analysis of brain and cerebellum microsomes
Fig. 2 shows the distribution of RyRs and IP3Rs in bovine
cerebellum and WB -C microsomes, as detected by immunoblot
analysis with antiserum to skeletal-muscle RyR (Fig. 2a), mAb
to cardiac-muscle RyR (Fig. 2b) and antiserum to cerebellum
IP3R (Fig. 2c). No immunoreactivity to WB -C or cerebellum
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Fig. 3. Isolation of bovine brain I3HIRyR
(a, b) Gradient sedimentation profiles of bovine brain RyR. Chaps-
solubilized WB -C microsomes were centrifuged on linear 10-20%
sucrose gradients and the approx. 30 S [3H]RyR peak fractions
13-16 pooled and concentrated. Concentrated fractions from (a)
were re-centrifuged on a second 10-20% linear sucrose gradient,
and the - 30 S fractions (10-16) concentrated separately. (c) SDS/
polyacrylamide gel of [3H]ryanodine peak fractions from gradient
(b). Samples of concentrated fractions (100 ,ul) were electrophoresed
through SDS/3-12 % polyacrylamide gradient gels and stained with
Coomassie Brilliant Blue. Solid arrowheads indicate positions of Mr
standards as in Fig. 2.
antiserum (Fig. 2a). Blots probed with a mAb to mammalian
cardiac-muscle RyR, however, revealed a single immunoreactive
high-M, band in WB - C, but not cerebellum, microsomes (Fig.
2b). Conversely, an immunoreactive band corresponding to the
cerebellum IP3R (Supattapone et al., 1988) was observed when
cerebellum microsomes were probed with IP3R antiserum (Fig.
2c). The immunoblot data suggest a relative enrichment of
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Fig. 4. Immunoblot analysis of sucrose-gradient fractions
Samples (120,u1) of sucrose-gradient fractions, obtained with bovine WB-C (a) and cerebellum (b) microsomes as described in Fig. 3, were
electrophoresed through 3-12% gradient gels, and transferred to Immobilon membranes. The WB -C blot was probed with cardiac-muscle RyR
mAb C2-997 (a), and the cerebellum blot with IP3R antiserum (b). Solid arrowheads indicate positions of Mr standards as in Fig. 2.
agreement with ryanodine-binding data described above. In
contrast, the IP3R is enriched in cerebellar microsomes, in
agreement with previous reports of IP3-binding studies (Worley
et al., 1987; Supattapone et al., 1988).
Purification of bovine brain RyR and immunoblot analysis
The [3H]ryanodine-labelled brain RyR was isolated from
bovine WB-C microsomes by centrifugation through sucrose-
density gradients as described for skeletal- and cardiac-muscle
RyRs (Lai et al., 1988a,b; Anderson et al., 1989). The [3H]-
ryanodine peak of Chaps-solubilized WB-C microsomes, mi-
grating with apparent sedimentation coefficient - 30 S, was
isolated by a double-sucrose-gradient procedure (Figs. 3a and
3b). SDS/PAGE analysis of the second gradient revealed specific
co-migration of a single high-M, band with the [3H]ryanodine
peak (Fig. 3c). Immunoblot analysis showed that the single high-
Mr band immunoreactive with cardiac-muscle mAb was present
only in the - 30 S ['H]ryanodine peak (Fig. 4a). The sediment-
ation profile of this high-Mr band migrating at - 30 S was
clearly different from that of the cerebellar IP3R, which migrated
in identical gradients at - 24 S (Fig. 4b). The mobility of the
large polypeptide co-migrating with the [3H]ryanodine peak (RF
= 0.12, Fig. 3c) was identical with the immunoreactive band
observed in WB -C microsomes (Fig. 2b) and - 30 S peak
fractions (Fig. 4a). Protein determination yielded 16 ,ug of
purified brain RyR from 45 mg ofWB -C protein. Assuming a
single high-affinity site per 30 S complex and Mr equivalent to
the muscle RyR (2.3 x 106), the ryanodine-binding density of
WB -C microsomes (Fig. la) indicates a quantitative receptor
yield of 25 ,sg (0.05 % of WB -C protein). The observed yield
of 16,g represents an overall protein recovery of 64 %. [3H]-
Ryanodine binding to the purified unlabelled receptor was not
quantified because of the low amounts of protein recovered.
Comparison of purified brain, cardiac- and skeletal-muscle RyRs
SDS/PAGE analysis of purified brain RyR on 3-12% gels
(Fig. 5) revealed a single high-Mr band (lane 3) that displayed an
identical mobility with the purified cardiac-muscle RyR (lane 4).
















Fig. 5. SDS/PAGE analysis of brain and muscle RyRs
4 5
Microsomes from bovine WB-C (lane 1; 15,g of protein) and
cerebellum (lane 2; 15 /sg), and the purified 30 S RyR from bovine
WB-C microsomes (lane 3; 0.5 ,ug), dog-cardiac-muscle SR (lane
4; 0.5 ,g), and rabbit skeletal-muscle SR (lane 5; 2,g) were
electrophoresed through 3-12% gradient gels and stained with
silver. Solid arrowheads indicate positions of Mr standards as in
Fig. 2.
with a relative mobility greater than that of the purified skeletal-
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Fig. 6. Morphology of the purified bovine brain RyR
Bovine WB -C RyR isolated in the absence of exogenous phospholipid was analysed by negative-stain electron microscopy. A montage of selected
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Fig. 7. Single-channel currents of bovine brain RyR complex reconstituted into a planar lipid bilayer
Bovine WB-C RyR isolated as described in Fig. 3(a) was incorporated into planar lipid bilayers for single-channel analysis. Upward deflections
represent channel openings. The baseline current is denoted by the bar to the left of the trace, labelled c (for channel closed state). (a) Traces 1
and 2, single-channel K(+ currents recorded in symmetrical 0.25 M-KCl buffer containing 50/tM free Ca2+. Holding potentials are + 20 mV and
-20 mV respectively. Traces 3 and 4, single-channel Ca2+ and K+ currents recorded after perfusion of the trans chamber with 50 mM-CaCl2.
Holding potentials are +52 mY and -48 mV respectively. (b) Current-voltage relationship. 0, K+ current: unitary conductance is 800 + 32 pS
(±+S.D., n = 1 5,. (A\), currents obtained after perfusing trans chamber with 50 mM-CaCl2, unitary Ca2+ conductance is 140 pS.
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cardiac-muscle RyR RF is slightly higher than that of skeletal-
muscle RyR (Inui et al., 1987b; Lai et al., 1988a), although
subsequent cDNA sequence analysis predicts similar Mr values
of approx. 565000 for the two rabbit muscle RyR isoforms
(Takeshima et al., 1989; Zorzato et al., 1990; Otsu et al., 1990;
Nakai et al., 1990).
Analysis ofWB -C (lane 1) and cerebellar (lane 2) microsomes
revealed a minor band of high Mr in WB - C membranes (arrow;
RF = 0.12), which corresponded in mobility to the purified brain
RyR (lane 3). The low abundance of this protein correlates with
the 0.05% relative RyR content derived from ryanodine-binding
studies described above. Further, this minor band was not
apparent in the cerebellum lane loaded at an identical protein
concentration (lane 2), in concert with our ryanodine-binding
data indicating a more than 10-fold lower RyR concentration in
cerebellum than in WB - C microsomes.
Electron microscopy of brain RyR
Brain RyR isolated in the absence of exogenous phospholipid
was examined by negative-stain electron microscopy. Fig. 6
illustrates selected enlarged images of bovine brain RyR dis-
playing the presence offour-leafclover-like (quatrefoil) structures
characteristic of skeletal- and cardiac-muscle RyRs (Lai et al.,
1988b; Anderson et al., 1989; Wagenknecht et al., 1989), and
morphologically identical with the 'feet' structures spanning the
T-SR junctional gap (Ferguson et al., 1984). The brain RyR
quatrefoil from the tip of one leaf to the tip of the opposite
one is - 34 nm, with each leaf - 13 nm in diameter. Stain
accumulations of - 3 nm diameter were apparent at the centre of
each leaf. In addition, a central depression or hole of 1-2 nm was
apparent at the centre of the complex surrounded by a ring, -
12 nm diameter, of higher protein density. This central - 12 nm
region of the quatrefoil has been suggested to form the trans-
membrane channel-forming domain of the muscle RyR (Lai
et al., 1988b; Wagenknecht et al., 1989).
Single-channel recordings of brain RyR
Brain RyRs were reconstituted into planar lipid bilayers in
symmetric 0.25 M-KCI buffer containing 50 4uM free Ca2l. Use
of symmetric univalent cation buffers has been shown to facilitate
reconstitution of skeletal- and cardiac-muscle RyR channels (Lai
et al., 1988b; Liu et al., 1989a; Anderson et al., 1989). Also,
univalent cations give currents of larger amplitude than those
observed when using Ca2+ ions as the current carrier. Fig. 7a
(upper two recordings) shows current traces from an incorporated
single channel after addition of the channel protein to the cis
chamber. The channel was partially activated at positive and
negative holding potentials, and displayed a unitary K+ con-
ductance of 800 pS (Fig. 7b). The two lower recordings of Fig.
7(a) show the current traces obtained after perfusion of the trans
chamber with 50 mM-Ca2l. The current-voltage plot under these
conditions (Fig. 7b) indicates a unitary Ca2+ conductance of
140 pS. By using identical recording conditions, unitary con-
ductances for skeletal- and cardiac-muscle Ca2+-release channels
of 770 and 745 pS for K+ ions, and 145 and 148 pS for Ca2+ ions
respectively were obtained. From the reversal potential of
+ 10 mV observed after trans chamber perfusion with Ca2+, a
permeability ratio for Ca2+ versus K+ ions (Pca/1K) of 6.5 was
calculated for the reconstituted brain RyR channel.
Pharmacology of brain RyR channel
The pharmacological responses of the brain RyR channel after
the successive addition of various agents are illustrated in
recordings from a single reconstituted channel (Fig. 8). Trace 1
shows a K+-conducting channel in 50 /uM free Ca2+. As observed
for skeletal- and cardiac-muscle RyR channels, the open prob-
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Fig. 8. Pharmacological responses of bovine brain RyR channel
Single-channel currents, shown as upward deflections, were recorded
in symmetrical 0.25 M-KCI buffer. The baseline current is denoted
by the bar to the left of the trace, denoted c (for closed channel
state). Holding potential = -20 mV. Trace 1, 50 /LM free Ca2" cis,
PO = 0.308. Trace 2, 91 nm free Ca2" cis, Po = 0.005. Trace 3, 1.7 /tM
free Ca2" cis, Po = 0.145. Trace 4, after addition of 0.3 /iM-IP3 cis,
PO = 0.297. Trace 5, after addition of 1P3 to 10 ,lM cis, P0 = 0.217.
Trace 6, after addition of 2 mg of heparin/ml cis, Po = 0.015. Trace
7, after addition of 2.4 mM-ATP cis, Po = 0.084. Trace 8, after
addition of 10 ,uM-ryanodine cis, channel entered modified con-
ductance state. Trace 9, after addition of ryanodine to 3 mm cis,
channel entered closed state. Similar effects to these were observed
in three different experiments.
ability (PF) of the brain channel decreased on lowering cis free
Ca2+ from 50 /uM to 90 nm (trace 2), and could subsequently be
elevated to half the control value by raising cis free Ca2+ to
1.7/,M (trace 3). In traces 4-6, the sensitivity of the Ca2+-
activated channel to IP3 and heparin was tested. On addition of
0.3#LM-1P3 cis, a 2-fold increase in PO was observed (trace 4).
Further increase in IP3 cis to 10/M resulted in a decrease in
channel activity (trace 5). Heparin addition to 1 mg/ml cis was
without a significant effect (result not shown). However, further
addition of heparin to 2 mg/ml cis greatly decreased channel
activity (trace 6). Partial activation of the channel by millimolar
concentrations of ATP was evident in trace 7. The extent of
channel activation by ATP illustrated in trace 7, however, was
less than that obtained in other recordings, where PO values
usually increased from - 0.3 (in 50/M free Ca2+) to 0.9 on
addition of millimolar ATP cis (not shown). Traces 8 and 9
confirm the identity of the reconstituted brain protein as a
ryanodine-sensitive channel. On addition of 10 ,sM-ryanodine cis,
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Fig. 10. LocalIzadon in situ of RyR mRNA in rat hippocampus
Sagittal sections of rat brain were hybridized with digoxigenin-labelled cardiac-muscle RyR RNA. Hybridization pattern of the hippocampus with
antisense RNA probe (a) and sense RNA probe (b) are shown. Enlarged views of dentate gyrus (DG) granule cells (c), and pyramidal cells of
hippocampal fields CA3 (a), and CAI (e) are taken from (a). The arrowhead in (a) shows the junction between CAI and CA3. Scale bars in (a)
and (b) = 500 ,m, and those in (c), (d) and (e) = 100 ,um.
the characteristic formation of a fully open channel state of
decreased conductance was observed (trace 8). The order of IP3
and ryanodine addition was not changed, because ryanodine
modification renders the channel insensitive to regulation by
most effector molecules (Rousseau et al., 1987). In the presence
of 3 mM-ryanodine cis, the channel abruptly closed and remained
inactive for the remainder of the recording (trace 9). Identical
effects of low and high concentrations of ryanodine have been
shown for the bilayer reconstituted muscle RyR channel (Lai et
al., 1989).
Localization of brain RyR
Immunocytochemical localization of the mammalian brain
RyR using a cardiac-muscle RyR mAb revealed its wide dis-
tribution throughout adult rat forebrain (Fig. 9). Immunoreactive
regions of the brain were hippocampus (Fig. 9a), cortex (Fig. 9b),
caudate-putamen (Figs. 9c and 9d), septum, amygdala, olfactory
bulb, thalamus and hypothalamus. High levels of RyR
immunoreactivity were found throughout the cortex and dentate
gyrus of the hippocampus. Immunostain was observed in the
layers of dendrites and cell bodies (Fig. 2b and inset), and in the
region corresponding to mossy fibres (Fig. 9a). By comparison,
and in accord with our [3H]ryanodine-binding studies, there
appeared to be less immunoreactivity in the mammalian cer-
ebellum, including the Purkinje cells (not shown). No staining of
brain sections was observed in controls using either mouse IgG
or after preabsorption ofmAb with purified cardiac-muscle RyR
(not shown).
Hybridization in situ of cardiac-muscle RyR antisense RNA to
sagittal sections of adult rat brain indicated that RyR RNA
expression was widely distributed throughout the brain, and was
particularly enriched in the hippocampal formation. Fig. 10
illustrates the abundant expression of RyR RNA in the hip-
pocampus. Localization of RyR RNA to the pyramidal layers of
hippocampal fields CAl and CA3 (Figs. lOa, lOd and lOe), with
even higher levels present in the granule cell layer of the dentate
gyrus (Figs. 1Oa and lOc), was apparent. Hybridization with the
control RNA sense strand revealed little signal, even in layers of
hippocampus that are densely packed with neuronal cell bodies
(Fig. lOb). In agreement with our [3H]ryanodine-binding and
immunolocalization studies, there appeared to be lower levels of
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Fig. 11. Northern-blot analysis
Poly(A)+ RNA from bovine brain (lane 1), cardiac muscle (lane 2)
and skeletal muscle (lane 3) was electrophoresed through a 0.8%
agarose gel and transferred to Genescreen membrane. Blotswere
hybridized with mammalian cDNA probes derived from the cardiac-
muscle RyR (a) or skeletal-muscle RyR (b), as described in the
Experimental section. Solid arrowheads indicate positions of yeast
18 S and 28 S RNA standards.
Northern-blot analysis
mRNA isolated from bovine whole brain, skeletal- and car-
diac-muscle tissue was hybridized to cDNA probes specific for
the mammalian cardiac- or skeletal-muscle RyR (Fig.11). Both
bovine cardiac-muscle and brain mRNA contained a transcript
of approx. 16 kb which hybridized specifically with a cardiac-
muscle cDNA probe (Fig. lla). A cardiac RyR mRNA of
approx. 16 kb has previously been identified in rabbit heart (Otsu
et al., 1990; Nakai et al., 1990). In contrast, hybridization of the
skeletal-muscle RyR cDNA probe to an approx. 16 kb band was
observed only with skeletal-muscle mRNA (Fig.1 lb). An approx.
16 kb skeletal-muscle RyR mRNA has been shown in rabbit and
human skeletal muscle (Takeshima et al., 1989; Zorzato et al.,
1990). These hybridization data (Fig. 11) suggest that a cardiac
RyR-specific mRNA is expressed in brain.
DISCUSSION
Evidence for a brain RyR
Early morphological observations on rat brain by Henkart et
al. (1976) identified the presence of bridging structures between
surface and intracellular membranes, with an arrangement and
dimensions similar to the 'feet' structures found between the T-
and SR membranes in muscle. Evidence for a ryanodine- and
caffeine-sensitive intracellular Ca2+ store was subsequently
demonstrated in rat sympathetic neurons using fluorimetric and
electrophysiological measurements of intracellular Ca21 (Thayer
et al., 1988a,b; Lipscombe et al., 1988), suggesting the existence
of an intracellular Ca2+ channel in brain with properties similar
to the muscle SR Ca2+ channel. Ashley (1989) described binding
of [3H]ryanodine to a high-affinity site of Kd approx. 3 nm in rat
brain microsomes. Incorporation of the rat brain microsomes
into planar lipid bilayers resulted in the appearance of a Ca2+_
conducting channel that could be activated by ATP, caffeine and
IP3. Ryanodine transformed the rat brain channel into a state of
lower conductance (Ashley, 1989), as previously observed for
Ca2+-release channels of muscle SR (Rousseau etal., 1987; Lai
etal., 1989). RNA-blot analysis using a cardiac-muscle RyR
cDNA probe detected a low-abundance mRNA of approx. 16 kb
in rabbit brain (Otsu etal., 1990). These previous studies are all
in accord, suggesting that an RyR is present in mammalian brain
with properties similar to the mammalian muscle RyRs.
Brain RyR-Ca2+-release channel is a cardiac isoform
Earlier biochemical studies indicated the presence of a mam-
malian brain RyR with an apparent sedimentation coefficient of
approx. 30S comprising high-M, subunits (Lai et al., 1990;
McPherson & Campbell, 1990; McPherson etal. 1990), identical
with that observed for skeletal- and cardiac-muscle RyRs (Lai et
al., 1988b; Anderson et aL, 1989). Immunoblot analysis showed
cross-reactivity of selected skeletal-muscle RyR antisera and a
peptide antiserum to a high-Mr band from rabbit brain that
migrated close to the skeletal-muscle RyR (McPherson & Camp-
bell, 1990; McPherson et al., 1991). However, the lack of
immunoreactivity to the brain RyR of other skeletal-muscle RyR
antisera (Fig. 2a; McPherson & Campbell, 1990), and of skeletal-
muscle RyR-specific mAbs (McPherson and Campbell, 1990;
F. A. Lai, unpublished work), indicates that the brain RyR,
although similar to, is not identical with the skeletal-muscle
RyR. In the present study, we have identified the 30S bovine
brain RyR channel complex to display an immunological cross-
reactivity specifically to cardiac-muscle RyR mAbs (Figs. 2b and
4a), and an electrophoretic mobility identical with that of the
purified cardiac RyR (Figs. 3c and 5). Northern-blot hybrid-
ization analysis with a cardiac RyR-specific cDNA probe reveals
specific labelling of a 16 kb transcript in bovine brain mRNA
(Fig. 11). Brain mRNA did not hybridize to skeletal-muscle
RyR-specific cDNA probes under identical conditions. These
studies strongly suggest that mammalian brain specifically ex-
presses a cardiac RyR-Ca2+-release channel isoform, although
we cannot at present exclude the possibility of a distinct neuronal
RyR isoform. Table1 summarizes the properties of the 30S RyR
isolated from bovine brain, dog cardiac muscle and rabbit
skeletal muscle. All three RyRs exist as tetrameric complexes of
high-Mr subunits arranged into a four-leaf-clover pattern. The
RyR channels readily conduct univalent cations with a large
unitary conductance of 700-800 pS for K+ ions, and possess low-
and high-affinity ryanodine-binding sites, occupation of which
results in disparate effects on single-channel conductance. RyR
channel activity can be increased by micromolar concentrations
of Ca2+ and millimolar concentrations of ATP, and decreased by
millimolar concentrations of Mg2+ and micromolar concen-
trations of Ruthenium Red.
IP3 effect on brain RyR channel
Single-channel recordings of the microsomal (Ashley, 1989),
and solubilized (Fig. 8), brain RyR incorporated into a planar
lipid bilayer indicate that cis addition of low concentrations ofIP3 can weakly activate channel opening. Only at high con-
centrations of heparin, in excess of 1 mg/ml, could the 1P3
activation be reversed- (Fig. 8). In contrast, IP3 binding and
activation of the cerebellar IP3R could be fully inhibited by
heparin concentrations of 100 ,tg/ml (Ferris et al., 1989). The
basis for this common observation of activation of RyR and
IP3R channels by IP3 is unclear at present. Although significant
sequence similarity is present within the putative transmembrane
channel-forming domain at the C-terminus of the RyR and IP3R(Furuichi et at., 1989), the structure(s) within the IP3R involved
in IP3binding is now believed to include the N-terminus (Mignery
& Suidhof, 1990; Miyawaki etat., 1991), where sequence similarity
1992
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Cardiac Ca2+-release channel in mammalian brain
Table 1. Comparison of properties of ryanodine receptors purified from
bovine brain, dog cardiac muscle and rabbit skeletal muscle
N.D., not determined.
Cardiac Skeletal
Property Brain muscle muscle
1. Apparent sedimentation 30 S 30 St 30 St
coefficient
2. RF in SDS/3-12% 0.12 0.12 0.10
polyacrylamide gels
3. Morphology Quatrefoil Quatrefoilt Quatrefoilt




High-affinity (Kd) 3 nM 3 nmt 6 nm¶
Low-affinity Yes Yes** Yes¶
6. Ryanodine modification Yes Yest Yes¶
Sublevel conductance
state (UM)
Closing of channel (mM) Yes N.D. Yes¶
7. Single-channel conductance*
In 0.25 M-K+ 800 pS 745 pS 770 pS
In 0.05 M-Ca2" 140 pS 148 pS 145 pS
8. Regulation
Activation by Ca2" Yes Yest Yest
and ATP
Activation by IP3 Occasional N.D. Occasionaltt
Inhibition by Mg2" Yes Yest Yest
and Ruthenium Red
* Measured using conditions described in Fig. 7(b).
t Data from Anderson et al. (1989).
t Data from Lai et al. (1988b).
§ Data from Otsu et al. (1990) and Nakai et al. (1990).
ll Data from Takeshima et al. (1989) and Zorzato et al. (1990).
¶ Data from Lai et al. (1989).
** Data from Pessah & Zimanyi (1991).
tt Data from Liu et al. (1989b).
with the RyR is lower. A similar weak activation of RyR
channels purified from mammalian and amphibian muscle, by cis
addition of IP3, has also been observed (Suarez-Isla et al., 1988;
Liu et al., 1989b). Conversely, ATP, a potent muscle RyR
channel activator (Meissner, 1984; Smith et al., 1985), has been
shown to stimulate the purified cerebellum IP3R channel (Ferris
et al., 1989; Maeda et al., 1991), and calmodulin, a muscle RyR
channel antagonist (Meissner, 1986), also interacts with the
purified IP3R (Maeda et al., 1991). These similarities in the
pharmacological profile of the RyR and IP3R channels are
consistent with those observed for their sedimentation behaviour
(Fig. 4), morphology (Fig. 6; Chadwick et al., 1990), subunit
structure (Lai et al., 1989; Maeda et al., 1991) and primary
structure (Furuichi et al., 1989; Mignery et al., 1989). However,
no effect of ryanodine on the IP3R channel incorporated into
planar lipid bilayers has yet been reported. One distinctive
difference observed in single-channel recordings of the IP3R and
RyR was the lower permeability to univalent cations of the
reconstituted IP3R channel. The unitary conductance for Na+
ions of 21 pS in 100-500 mM-Nat for the IP3R channel (Maeda
et al., 1991) is in contrast with the value of 400 pS observed for
the skeletal RyR under similar recording conditions (Smith et al.,
1988; Liu et al., 1989a).
Localization of brain RyR
Localization of the mammalian brain RyR by immuno-
cytochemistry and hybridization in situ using cardiac-muscle
RyR-specific mAb and antisense RNA respectively revealed
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prominent reactivity in the hippocampal formation, particularly
in the molecular layer of the dentate gyrus and in the terminals
of cells projecting from this area into the CA3 field of the
hippocampus (Figs. 9 and 10). This hippocampal enrichment in
RyR is in accord with observations from ryanodine-binding
studies to membrane fractions isolated from various rabbit brain
regions (McPherson & Campbell, 1990), and with [3H]ryanodine
autoradiography (Padua et al., 1991), indicating brain RyR was
particularly enriched in the hippocampus. The studies by hy-
bridization in situ (Fig. 11) complement the immunocytochemical
analysis (Fig. 10) and indicate markedly high levels ofRyR RNA
expression in the granule cells of dentate gyrus with a lower level
of expression in the pyramidal cells of the CA3 and CAl field of
the hippocampus. The functional significance of these obser-
vations is not known, although the importance of intracellular
Ca2+ stores was demonstrated in a recent study which showed
that in cultured Xenopus spinal neurons, Ca2+-induced release of
Ca2+ promotes cell differentiation (Holliday et al., 1991). This
Ca2+-sensitive mechanism of intracellular Ca2+ release is in
concurrence with our observation that the brain RyR channel is
a cardiac-specific isoform.
A recent immunocytochemical study of the avian cerebellum
RyR has shown it to be enriched in the Purkinje neurons
(Ellisman et al., 1990), as has been found for the IP3R (Ross et
al., 1989). The avian cerebellum Purkinje neuron RyR was
localized by immunogold electron microscopy to the smooth
and rough endoplasmic reticulum and subsurface membrane
cisternae, and found to co-localize with IP3Rs throughout the
Purkinje neuron, with the exception of dendritic spines where
only the IP3Rs were evident (Walton et al., 1991). In contrast,
our ryanodine-binding and localization data indicate that ex-
pression of the mammalian RyR and IP3R in cerebellum and
whole brain displays an inverse relationship, with the RyR in
mammalian cerebellum present at approx. 10-fold lower con-
centrations than in the rest of the brain. The relatively disperse
distribution of the neuronal RyR within intracellular membrane
compartments of the Purkinje neuron (Walton et al., 1991), in
comparison with specific localization ofmuscle RyR to the T-SR
junctions (Ferguson et al., 1984), makes the assignment of a
plausible role for this intracellular channel more challenging.
Studies of the skeletal- and cardiac-muscle RyR channels have
indicated that they are coupled to a sarcolemmal voltage-sensing
and a Ca2+-induced Ca2l-release mechanism respectively (Rios &
Pizarro, 1988). Our observations that the brain RyR channel is
a cardiac isoform, and likewise sensitive to activation by micro-
molar concentrations of Ca2+, would suggest a role of Ca2+ ions
in regulating this channel, possibly via the Ca2+-induced Ca2+-
release mechanism (Thayer et al., 1988a,b; Lipscombe et al.,
1988; Holliday et al., 1991) that predominates during E-C
coupling in cardiac cells (Cannell et al., 1987; Nabauer et al.,
1989). In conclusion, the studies reported here suggest that the
RyR present in brain probably plays an important role in
neuronal intracellular Ca2' homoeostasis generally, and may be
of particular significance in the regulation of Ca2" levels pre- and
post-synaptically.
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